# Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

> **NCT06711978** · NA · NOT_YET_RECRUITING · sponsor: **Pusan National University Yangsan Hospital** · enrollment: 66 (estimated)

## Conditions studied

- CIPN
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- CIPN in Adjuvant Breast Cancer Patients
- Duloxetine
- Mirogabalin

## Interventions

- **DRUG:** Mirogabalin
- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT06711978
- **Lead sponsor:** Pusan National University Yangsan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06711978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06711978, "Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06711978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*